For citations:
Abrurakhmanov D.T., Morozov V.G., Nikitin I.G., Bogomolov P.O., Geyvandova N.I., Bessonova Ye.N., Bakulin I.G., Isakov V.A., Zhdanov K.V., Mayevskaya M.V., Nurmukhametova Ye.A., Burnevich E.Z., Chesnokov Ye.V., Pasechnikov V.D., Hill A., Lonjon-Domanec I., Kizhlo S.N. Safety and efficacy of telaprevir in treatment of a chronic hepatitis C in patients of the Russian population included in early access program study. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2014;24(1):39-46. (In Russ.)
Email this article 
